Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 133.00
Bid: 130.00
Ask: 136.00
Change: 0.00 (0.00%)
Spread: 6.00 (4.615%)
Open: 133.00
High: 133.00
Low: 133.00
Prev. Close: 133.00
NBS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Tender Offer

23 Feb 2023 15:43

RNS Number : 8980Q
Nationwide Building Society
23 February 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN (1) THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (THE UNITED STATES), (2) THE REPUBLIC OF ITALY, OR (3) ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

Nationwide Building Society announces final results of

its inaugural Open Market Repurchase Exercise

in respect of its Core Capital Deferred Shares

23 February 2023.  On 20 February 2023, Nationwide Building Society (Nationwide) announced (i) the launch of an open market repurchase facility (the OMR Facility) under which it may, from time to time and in its sole discretion, seek to repurchase limited numbers of the Core Capital Deferred Shares of £1 nominal amount each (ISIN: GB00BBQ33664) (the CCDS) issued by Nationwide and (ii) the commencement of the inaugural open market repurchase exercise under the OMR Facility (the OMR Exercise 2023-1).

The OMR Exercise 2023-1 was made on the terms and subject to the conditions contained in the announcement made by Nationwide on 20 February 2023 (the Launch Announcement). Capitalised terms used, but not defined, in this announcement have the meanings given to them in the Launch Announcement.

The Second OMR Tender Period expired at 3.00 p.m. (London time) on 23 February 2023, and Nationwide announces today the final results of the OMR Exercise 2023-1.

Final Results of OMR Exercise 2023-1

Nationwide announces that it has decided to set the Second OMR Acceptance Amount at 387,804 CCDS, and that Nationwide will accordingly accept for purchase CCDS validly tendered during the Second OMR Tender Period subject to application of a Scaling Factor of 65.01 per cent., as described in the Launch Announcement.

The expected settlement date for CCDS validly tendered during, and accepted for purchase in connection with, the Second OMR Tender Period is 27 February 2023 (the Second OMR Settlement Date).

On the Second OMR Settlement Date, holders of CCDS validly tendered for purchase during the Second OMR Tender Period and accepted for purchase will receive, for each CCDS purchased, an amount equal to the aggregate of (i) the Purchase Price of £128.93 per CCDS and (ii) an Amount Attributable to Potential Future Distributions of £1.94 per CCDS.

Following settlement on the Second OMR Settlement Date, Nationwide will have purchased an aggregate of 775,608 CCDS pursuant to the OMR Exercise 2023-1. Nationwide intends to hold all such CCDS purchased by it pursuant to the OMR Exercise 2023-1 in treasury, and future re-sales of any purchased CCDS may occur from time to time at the sole discretion of Nationwide. The Conditions of the CCDS provide that any such re-sale will not be subject to pre-emption rights.

Summary

Description of the CCDS

ISIN

Second OMR Acceptance Amount

Scaling Factor

Aggregate number of CCDS purchased by Nationwide pursuant to the OMR Exercise 2023-1

Aggregate number of CCDS outstanding following the OMR Exercise 2023-1

Nationwide's Core Capital Deferred Shares of £1 nominal amount each

GB00BBQ33664

387,804 CCDS

65.01 per cent.

775,608 CCDS

9,779,892 CCDS*

* This figure excludes the CCDS purchased by Nationwide pursuant to the OMR Exercise 2023-1, which (for so long as they are held by Nationwide in treasury) will be deemed not to be outstanding for certain purposes under the Conditions of the CCDS.

UBS AG London Branch (Telephone: +44 20 7568 1121; Attention: Liability Management Group; Email: ol-liabilitymanagement-eu@ubs.com) is acting as Dealer Manager in connection with the OMR Exercise 2023-1.

LEI of Nationwide Building Society: 549300XFX12G42QIKN82

DISCLAIMER

This announcement must be read together with the Launch Announcement. No offer or invitation to acquire any securities is being made pursuant to this announcement.

The distribution of this announcement and the Launch Announcement in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Launch Announcement come(s) are required by Nationwide and the Dealer Manager to inform themselves about, and to observe, any such restrictions.

The OMR Exercise 2023-1 has now expired and no additional CCDS will be accepted for purchase pursuant to the OMR Exercise 2023-1.

This announcement is made by Nationwide, and the Dealer Manager does not accept any responsibility for the contents of this announcement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTEDZGZZKFZGFZM
Date   Source Headline
25th Jul 201610:07 amRNSPublication of Final Terms
22nd Jul 201611:52 amRNSPublication of Final Terms
21st Jul 20163:03 pmRNSResult of AGM
19th Jul 20162:41 pmRNSPublication of Final Terms
19th Jul 20162:40 pmRNSPublication of Final Terms
7th Jul 201611:06 amRNSDoc re. Appointment of Senior Independent Director
23rd Jun 20161:38 pmRNSPublication of a Prospectus
21st Jun 20162:55 pmRNSNotice of Results of Covered Bondholder Meeting
7th Jun 20169:59 amRNSPost Stab Notice - Nationwide EUR1.25Bn .5% Oct 19
31st May 201611:17 amRNSPost Stab Notice - Nationwide EUR1.25Bn .5% Oct 19
31st May 201610:22 amRNSPost Stabilisation Notice
26th May 20169:39 amRNSAnnouncement of a Consent Solicitation
24th May 20161:25 pmRNSPublication of Suppl.Prospcts
24th May 20167:00 amRNSPreliminary Results Announcement
23rd May 20167:00 amRNSDirectorate Change
6th May 20165:05 pmRNSPublication of Final Terms
6th May 20169:33 amRNSPost-Stabilisation Notice - Nationwide
5th May 20163:21 pmRNSPublication of Final Terms
4th May 20166:20 pmRNSPublication of Final Terms
3rd May 20163:14 pmRNSPublication of Final Terms
28th Apr 20169:24 amRNSPre Stabilisation Notice
27th Apr 20163:03 pmRNSPublication of Final Terms
27th Apr 20162:56 pmRNSPublication of Final Terms
22nd Apr 201612:00 pmRNSPublication of Final Terms
20th Apr 20165:41 pmRNSPublication of Final Terms
19th Apr 201612:50 pmRNSPublication of Amended Final Terms
18th Apr 201611:54 amRNSPublication of Final Terms
15th Apr 201611:50 amRNSPublication of Final Terms
12th Apr 201612:33 pmRNSCCDS - Notification of adjustment to PIR cap
11th Apr 20165:39 pmRNSPublication of Final Terms
11th Apr 201610:59 amRNSPublication of Final Terms
24th Mar 201610:57 amRNSPublication of Final Terms
24th Mar 201610:54 amRNSPublication of Final Terms
21st Mar 20164:20 pmRNSPublication of Final Terms
18th Mar 201611:19 amRNSPublication of Final Terms
18th Mar 201611:19 amRNSPublication of Final Terms
18th Mar 201611:14 amRNSPublication of Final Terms
3rd Mar 201612:40 pmRNSPublication of Final Terms
3rd Mar 201612:33 pmRNSPublication of Final Terms
26th Feb 20165:13 pmRNSPublication of Final Terms
26th Feb 20165:07 pmRNSPublication of Final Terms
26th Feb 20165:07 pmRNSPublication of Final Terms
23rd Feb 20166:14 pmRNSPublication of Final Terms
23rd Feb 20167:00 amRNSPublication of Final Terms
18th Feb 201612:31 pmRNSPublication of Final Terms
17th Feb 20165:10 pmRNSPublication of Final Terms
12th Feb 20162:54 pmRNSPublication of Supplement - Replacement
12th Feb 20162:42 pmRNSPublication of Supplement
12th Feb 20167:00 amRNSInterim Management Statement
2nd Feb 201610:00 amRNSJOE GARNER TO JOIN AS CEO ON 5 APRIL 2016

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.